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Abstract
Background: Preterm infants in neonatal intensive care units frequently receive red blood cells (RBC) transfusions due to
the anemia of prematurity. A number of variables related to gestational age, severity of illness and transfusion practices
adopted in the neonatal unit where the neonate was born may contribute to the prescription of RBC transfusions.
This study aimed to analyse the frequency and factors associated with RBC transfusions in very-low-birth-weight
preterm infants.
Methods: A prospective cohort of 4283 preterm infants (gestational age: 29.9 ± 2.9 weeks; birth weight: 1084 ± 275 g)
carried out at 16 university hospitals in Brazil between January 2009 and December 2011 was analysed. Factors
associated with RBC transfusions were evaluated using univariate and multiple logistic regression analysis.
Results: A total of 2208 (51.6 %) infants received RBC transfusions (variation per neonatal unit: 34.1 % to 66.4 %). RBC
transfusions were significantly associated with gestational age (OR: -1.098; 95%CI: -1.12 to -1.04), SNAPPE II score
(1.01; 1.00-1.02), apnea (1.69; 1.34-2.14), pulmonary hemorrhage (2.65; 1.74-4.031), need for oxygen at 28 days of life
(1.56; 1.17-2.08), clinical sepsis (3.22; 2.55-4.05), necrotising enterocolitis (3.80; 2.26-6.41), grades III/IV intraventricular
hemorrhage (1.64; 1.05-2.58), mechanical ventilation (2.27; 1.74-2.97), use of umbilical catheter (1.86; 1.35-2.57),
parenteral nutrition (2.06; 1.27-3.33), >60 days of hospitalization (5.29; 4.02-6.95) and the neonatal unit where the
neonate was born.
Conclusions: The frequency of RBC transfusions varied among neonatal intensive care units. Even after adjusting for
adverse health conditions and therapeutic interventions, the neonatal unit continued to influence transfusion practices
in very-low birth-weight infants.
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Background
Preterm infants are at greater risk of developing anemia
in comparison to full-term newborns, especially when
admitted to an intensive care unit [1, 2]. Red blood cell
(RBC) transfusions are one of the most employed strat-
egies to correct anemia in preterm infants and have been
associated with adverse health conditions and death,
especially among preterm infants [3–6].
Understanding the events that increase the likelihood
of RBC transfusions can contribute to the rational use of
blood products in very low birth weight infants. Litera-
ture reports that RBC transfusions in preterm neonates
are associated with clinical severity, phlebotomy blood
loss and use of liberal criteria for the indication of trans-
fusions. Among 640 newborns with a mean birth weight
of 880 g and gestational age of 26 weeks, Fabres et al.
found that 85 % of them received at least one red blood
cell transfusion and that the transfusion volume was as-
sociated with birth weight, gestational age, age at first
transfusion and the use of inotropic drugs [7]. Analyzing
147 newborns with a gestational age of 23.6 to 35.7 weeks
and a birth weight of 460 to 1495 g, Mimica et al. found
that number of transfusions was associated with birth
weight, phlebotomy blood loss, duration of mechanical
ventilation, peri-intraventricular hemorrhage and the use
of liberal RBC transfusion guidelines. Every 10 mL/kg of
blood lost increased the number of transfusions by 0.66;
every 10 days on mechanical ventilation increased the
number of transfusion by 0.59; and the adoption of liberal
criteria increased this number by 0.55 [1]. A multicenter
study carried out in seven neonatal units found that phle-
botomy blood loss of 10 mL/kg increased the number of
RBC transfusions by 27 % (95 % confidence interval: 23 to
30 %).
In this context, the aim of the present study was to
analyze the frequency of red blood cell transfusions in
very-low-birth-weight preterm infants and factors asso-
ciated with this procedure in neonatal intensive care
units in Brazil.
Methods
Data collected prospectively from 16 neonatal intensive
care units at university hospitals located in seven states
in Brazil were analyzed for this study. At each unit, clin-
ical maternal and neonatal data considered essential to
improvements in the quality of clinical care were rou-
tinely collected using a specific chart. At the time of the
data collection for this study, delayed cord clamping or
cord milking was not a routine practice at these neonatal
units. Each unit was identified with a different letter of
the alphabet (A to P).
The research project was approved by the Research
Ethics Committee of each of the 16 network units
(Research Ethics Committee of Instituto Fernandes
Figueira - Fundação Oswaldo Cruz, Universidade Federal
de São Paulo, Universidade de São Paulo, Universidade de
Campinas, Universidade Federal do Rio Grande do Sul,
Universidade de São Paulo, Ribeirão Preto, Universidade
Estadual Paulista Júlio de Mesquita Filho, Pontif ícia
Universidade Católica do Rio Grande do Sul, Universidade
Estadual de Londrina, Instituto de Medicina Integral
Professor Fernando Figueira, Universidade Federal de
Uberlândia, Universidade do Estado de Rio de Janeiro,
Universidade Federal do Maranhão, Universidade Federal
de Minas Gerais, Faculdade de Ciências Médicas de Minas
Gerais). The Research Ethics Committee of Instituto
Fernandes Figueira - Fundação Oswaldo Cruz, Rio de
Janeiro was the leading center for database evaluation in
the network (CAAE: # 12244913.2.0000.5505). Since data
was obtained from a prospective database of all infants
born in the Brazilian Network on Neonatal Research in
the study period, informed consent was not obtained from
participants because it is not required according to Brazilian
regulations and IRB approval. The data were used for the
analysis of transfusion frequencies and factors associated
with the indication for RBC transfusions in very-low-
birth-weight newborns. The inclusion criteria were gesta-
tional age 22 to 36.9 weeks, birth weight < 1500 g and
births occurring in the 16 neonatal units of the Brazilian
Network on Neonatal Research. Infants with malforma-
tions and those who died in the first 12 h of life were ex-
cluded from the study.
The following factors were investigated: mother’s clinical
and obstetric history; birth conditions; sex; gestational age
(calculated from the best obstetric estimate or by the
neonatal evaluation) [8]; adequacy of birth weight to gesta-
tional age [9]; Apgar scores; clinical severity in the first 12 h
of life based on the Score for Neonatal Acute Physiology,
Perinatal Extension, Version II (SNAPPE II) [10]; neonatal
morbidity; and RBC transfusions during hospital stay. The
following clinical morbidities were analyzed: respiratory
distress syndrome [11]; pulmonary hemorrhage; apnea
[12]; dependence on oxygen at 28 days of life and/or at
36 weeks of corrected gestational age [13]; patent ductus
arteriosus [14]; clinical sepsis [15]; necrotizing enterocoli-
tis [16]; peri-intraventricular hemorrhage (diagnosed by at
least one head ultrasound during hospital stay) [17]; peri-
ventricular leukomalacia [18]; and retinopathy of prema-
turity according to The International Classification of
Retinopathy of Prematurity [19]. Data were also collected
on the use of mechanical ventilation, vasoactive drugs,
umbilical catheter placement and parenteral nutrition.
All neonatal units had written guidelines for RBC
transfusions based on the clinical condition of the new-
born and on the need for respiratory support or surgery
(Fig. 1). Four units employed criteria based on the
chronological age of the newborn. At these units, trans-
fusions in the first two weeks were indicated when the
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hematocrit was lower than 35 to 40 % in the presence of
respiratory support or surgery need, symptoms of
anemia or hematocrit lower than 25 to 35 % in asymp-
tomatic infants. Beginning in Week 3, RBC transfusions
were indicated when the hematocrit was lower than 25
to 30 % in symptomatic infants or if infants needed re-
spiratory support or surgery or hematocrit was lower
than 21 % in asymptomatic infants. The transfusion vol-
ume ranged from 10 to 20 mL/kg; 47 % of the neonatal
units administered 15 mL/kg at each transfusion.
The convenience sample was composed of all very-
low-birth-weight newborns who met the eligibility cri-
teria. According to literature [20], 15 patients are needed
for each independent variable in the logistic regression
model. Considering the 35 independent variables ana-
lyzed in the present study (19 clinical and 16 neonatal
units), a minimum of 525 patients was needed for the
present study.
Univariate analysis was performed to test the strength
of associations between the independent variables and
the occurrence of RBC transfusions, with the inclusion
of clinical variables considered important to the event.
Variables with a p-value < 0.20 were incorporated in
the multiple logistic regression analysis and those
with a p-value < 0.05 remained in the final model. Statis-
tical analysis was performed with the software SPSS 17.0
(IBM SPSS Statistics, Somers, NY), considering significant,
p < 0.05.
Results
A total of 4882 neonates with very-low-birth-weight
(gestational age: 22 to 36.9 weeks) were admitted to the
16 neonatal units during the study period. A total of 599
were excluded based on the eligibility criteria. Thus,
4283 were included in the study (mean gestational age:
29.9 ± 2.9 weeks: birth weight: 1084 ± 275 g); 2187
(51.1 %) were male; and 2937 (68.6 %) were delivered by
cesarean section. Apgar scores were 5.8 ± 2.5 at the first
minute and 8.0 ± 1.7 at the fifth minute. The SNAPPE II
score was 24 ± 24. A total of 2330 (54.4 %) required
positive-pressure ventilation in the delivery room.
During the hospital stay in the neonatal intensive care
unit, the following complications were recorded: re-
spiratory distress syndrome (n = 2755; 64.3 %), pulmon-
ary hemorrhage (n = 262; 6.1 %), persistent arterial duct
(n = 1443; 33.7 %), apnea (n = 1826; 42.6 %), oxygen de-
pendence at 28 days of life (n = 1086; 25.4 %), oxygen
dependence at a corrected gestational age of 36 weeks
Fig. 1 Percentage of neonatal units that indicate red blood cell transfusions when hematocrit is lower than 21 %, 24 %, 30 %, 35 %, 40 % or
45 %, according to clinical characteristics of newborns and need for respiratory support or surgery. MV: mechanical ventilation; MAP: mean airway
pressure; FiO2: inspired oxygen fraction; retic: reticulocytes count
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(n = 995; 23.2 %), clinical sepsis (n = 2563; 59.8 %), nec-
rotizing enterocolitis (n = 307; 7.2 %), any degree of
peri-intraventricular hemorrhage (n = 1101; 25.7 %),
grade III or IV intraventricular hemorrhage (n = 325;
7.6 %), periventricular leukomalacia (n = 264; 6.2 %) and
retinopathy of prematurity (n = 787; 18.4 %). Moreover,
2615 (61.1 %) neonates were submitted to mechanical
ventilation (median duration: 6 days; Q1-Q3: 2-16 days),
2757 (64.4 %) received an umbilical catheter, 465 (10.9 %)
received vasoactive drugs and 3802 (88.8 %) received par-
enteral nutrition (median duration: 11 days; Q1-Q3: 7-17
days). Median stay in the neonatal intensive care unit was
42 days (Q1-Q3: 26-64 days).
A total of 2208 (51.6 %) newborns received RBC trans-
fusions. Table 1 displays the frequency of transfusions at
each neonatal unit analyzed. Table 2 shows the charac-
teristics of the newborns who received transfusions and
those who did not.
The univariate logistic regression to analyze factors as-
sociated with the use of RBC transfusions is shown in
Table 3. Each neonatal unit was compared to Unit F,
which had the lowest rate of RBC transfusions (Table 3).
Multiple logistic regression analysis was then performed
in order to determine the odd ratios for receiving RBC
transfusions (Table 4).
Discussion
Considerable variability among neonatal intensive care
units was found regarding the frequency of RBC
transfusions. The following factors were associated with
indications for transfusions: lower gestational age, higher
SNAPPE II score, presence of apnea, pulmonary he-
morrhage, clinical sepsis, moderate/severe intraventricular
hemorrhage, necrotizing enterocolitis, bronchopulmonary
dysplasia, umbilical catheter use, parenteral nutrition, pro-
longed hospital stay and center. These variables are closely
Table 1 Number and percentage of infants transfused in each
neonatal unit
Neonatal units Included neonates Transfused neonates Percentage
A 168 68 40.5
B 881 394 44.7
C 249 148 59.4
D 153 69 45.1
E 303 161 53.1
F 217 74 34.1
G 334 190 56.9
H 226 150 66.4
I 263 131 49.8
J 122 52 42.6
K 343 223 65.0
L 227 143 63.0
M 273 94 34.4
N 181 130 71.8
O 134 69 51.5
P 210 112 53.3
Total 4283 2208 51.6
Table 2 Clinical characteristics of transfused vs. not transfused
infants
Transfused
(n = 2208)
Non-transfused
(n = 2075)
p
Gestational age (weeks) 28.8 ± 2.6 31.1 ± 2.7 <0.001
Gestational age <28 weeks
[n (%)]
798 (36.1 %) 230 (11.1 %) <0.001
Birth weight (grams) 971 ± 254 1205 ± 242 <0.001
Birth weight <1000 grams
[n (%)]
1211 (54.8 %) 380 (18.3 %) <0.001
5th minute Apgar <7
[n (%)]
428 (19.4 %) 184 (8.9 %) <0.001
SNAPPE II (score) 30 ± 22 18 ± 18 <0.001
Respiratory distress
syndrome [n (%)]
1749 (79.2 %) 1006 (48.5 %) <0.001
Apnea [n (%)] 1168 (52.9 %) 658 (31.7 %) <0.001
Pulmonary hemorrhage
[n (%)]
216 (9.8 %) 46 (2.2 %) <0.001
Patent ductus arteriosus
[n (%)]
955 (43.3 %) 488 (23.5 %) <0.001
Clinical sepsis [n (%)] 1808 (81.9 %) 755 (36.4 %) <0.001
Necrotizing enterocolitis
[n (%)]
266 (12.0 %) 41 (2.0 %) <0.001
PIVH grade 3-4 [n (%)] 240 (10.9 %) 85 (4.1 %) <0.001
Periventricular
leukomalacia [n (%)]
183 (8.3 %) 81 (3.9 %) <0.001
Retinophaty of
prematurity [n (%)]
514 (23.3 %) 273 (13.2 %) <0.001
Need for oxygen
at 28 days of life [n (%)]
799 (36.2 %) 287 (13.8 %) <0.001
Need for O2 therapy
at 36 weeks [n (%)]
485 (22.0 %) 153 (7.4 %) <0.001
Use of umbilical catheter
[n (%)]
1677 (76.0 %) 1080 (52.0 %) <0.001
Need for mechanical
ventilation [n (%)]
1848 (83.7 %) 767 (37.0 %) <0.001
Duration of mechanical
ventilation (days)
13 ± 19 3 ± 8 <0.001
Need for vasoactive drugs
[n (%)]
328 (14.9 %) 119 (5.7 %) <0.001
Use of paraenteral nutrition
[n (%)]
2136 (96.7 %) 1666 (80.3 %) <0.001
Duration of hospitalization
(days)
59 ± 41 35 ± 20 <0.001
Hospitalization > 60 days
[n (%)]
1053 (47.7 %) 184 (8.9 %) <0.001
Intra-hospital death [n (%)] 662 (30.0 %) 300 (14.5 %) <0.001
SNAPPE II Morbidity and mortality risk scores, PIVH peri-intraventricular hemorrhage
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interrelated and, to some extent, reflect the morbidities
and procedures often described for very-low-birth-weight
newborns. However, the cross-sectional design of this in-
vestigation does not allow the determination of cause-
and-effect relationships between these variables and the
transfusion of RBC [21].
Variability in the frequency of RBC transfusions is
often reported in literature [7, 22–24]. This variability
may be due to the increasing survival rate of premature
infants with lower gestational ages [25], but is also likely
due to a lack of evidence-based criteria for the indication
of transfusions [26]. Thus, the transfusion rate varies
among neonatal units due to the severity of the patients’
condition. In the present study, patients with higher
SNAPPE II score had higher likelihood of being trans-
fused. SNAPPE II score is related with mortality and
morbidity [10] and may be associated with red blood cell
transfusions [4–7]. Kling et al. described a prediction
model for transfusion in preterm neonates based on
phlebotomy blood loss and clinical severity score, even
after adjusting for phlebotomy blood loss [27].
The restrictiveness of the transfusion guidelines may
also contribute to the transfusion rates. A study carried
out in 11 countries involving interviews with 1018 neo-
natologists found that only 51.1 % of the neonatal units
have written guidelines for the indication of transfu-
sions [28].
A number of studies report an increase in adverse health
conditions associated with RBC transfusions in premature
infants, such as necrotizing enterocolitis [5, 29–31],
Table 3 Unadjusted odds ratio of receiving RBC transfusions
according to infant’s characteristics and neonatal unit
OR 95 % CI p
Gestational age (weeks) 0.731 0.713 – 0.750 <0.001
Birth weight < 1000 grams 5.418 4.714 – 6.228 <0.001
5th minute Apgar <7 2.472 2.055 – 2.973 <0.001
SNAPPE II (score) 1.033 1.029 – 1.037 <0.001
Respiratory distress syndrome 4.049 3.541 – 4.630 <0.001
Apnea 2.419 2.135 – 2.740 <0.001
Patent ductus arteriosus 2.479 2.172 – 2.828 <0.001
Clinical sepsis 7.903 6.867 – 9.094 <0.001
Necrotizing enterocolitis 6.795 4.862 – 9.496 <0.001
PIVH grades 3-4 2.855 2.212 – 3.685 <0.001
Need for oxygen at 28 days of life 1.625 1.502 – 1.757 <0.001
Retinophaty of prematurity 2.003 1.705 – 2.353 <0.001
Use of umbilical catheter 2.910 2.555 – 3.314 <0.001
Need for mechanical ventilation 8.754 7.581 – 10.109 <0.001
Use of vasoactive drugs 2.868 2.304 – 3.570 <0.001
Need for parenteral nutrition 7.870 6.009 – 10.308 <0.001
Intra-hospital death 2.534 2.135 – 2.740 <0.001
Unit M 1.015 0.697 – 1.477 0.939
Unit A 1.341 0.883 – 2.036 0.169
Unit J 1.436 0.910 – 2.264 0.120
Unit B 1.563 1.146 – 2.133 0.005
Unit D 1.587 1.038 – 2.427 0.033
Unit I 1.918 1.324 – 2.778 0.001
Unit O 2.051 1.321 – 3.185 0.001
Unit E 2.176 1.518 – 3.118 <0.001
Unit P 2.208 1.495 – 3.263 <0.001
Unit G 2550 1.789 – 3.635 <0.001
Unit C 2.832 1.941 – 4.132 <0.001
Unit L 3.290 2.229 – 4.854 <0.001
Unit K 3.591 2.511 – 5.136 <0.001
Unit H 3.814 2.573 – 5.654 <0.001
Unit N 4.926 3.209 – 7.561 <0.001
SNAPPE II Morbidity and mortality risk scores, PIVH peri-intraventricular hemorrhage
Table 4 Final model of multiple logistic regression for factors
associated with RBC transfusions
OR IC 95 % p
Gestational age (weeks) -1.098 -1.151 – -1.042 <0.001
SNAPPE II 1.011 1.004 – 1.017 0.001
Apnea 1.692 1.339 – 2.138 <0.001
Pulmonary hemorrhage 2.648 1.740 – 4.031 <0.001
Clinical sepsis 3.217 2.553 - 4.054 <0.001
PIVH grades 3-4 1.642 1.046 -2.576 0.031
Necrotizing enterocolitis 3.804 2.258 – 6.407 <0.001
Need for oxygen at 28 days of life 1.562 1.173 – 2.081 0.002
Use of umbilical catheter 1.864 1.352 – 2.569 <0.001
Need for mechanical ventilation 2.271 1.740 – 2.966 <0.001
Use of parenteral nutrition 2.058 1.271 – 3.332 0.003
Hospitalisation >60 days 5.286 4.020 – 6.949 <0.001
Unit B 2.246 1.156 – 4.365 0.017
Unit O 2.822 1.230 – 6.470 0.014
Unit I 2.887 1.383 – 6.026 0.005
Unit P 2.961 1.365 – 6.423 0.006
Unit E 4.790 2.434 – 9.427 <0.001
Unit H 5.638 2.729 – 11.651 <0.001
Unit C 6.120 2.991 – 12.523 <0.001
Unit N 6.248 2.840 – 13.740 <0.001
Unit L 8.120 3.934 – 16.759 <0.001
Unit K 8.396 4.376 – 16.111 <0.001
Unit G 8.434 4.187 – 16.989 <0.001
Significance of the model p < 0.001. Final model adjusted for gestacional age,
SNAPPE II respiratory distress syndrome, apnea, pulmonar hemorrhage,
patente ductus arteriosus, clinical sepsis, necrotizing enterocolitis, need for
oxygen therapy at 28 days of life, peri-intraventricular hemorrhage grades 3-4
(PIVH 3-4), retinopathy of prematurity, use of umbilical cateter, need for mechanical
ventilation, use of parenteral nutrition, hospitalization > 60 days, and neonatal
unit where the neonate was born
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ventricular hemorrhage [3, 29] and death [4]. In a retros-
pective study involving 417 premature infants with grade I
peri-intraventricular hemorrhage, 24 developed grade III
hemorrhage and 22 developed grade IV hemorrhage after
RBC transfusions. The factors associated with the pro-
gression in hemorrhage severity were gestational age
(OR: 0.95; 95 % CI: 0.92 to 0.98) and having received a
transfusion (OR: 2.92; 95 % CI: 2.19 to 3.90) [3]. In a
meta-analysis that included retrospective and case-control
studies involving 4857 premature infants, Mohamed and
Shah found an association between RBC transfusion and
the occurrence of necrotizing enterocolitis 48 h following
the transfusion. After controlling for confounding factors,
the odds of developing enterocolitis was 2.01-fold (95 %
CI: 1.61-2.50) greater among the infants that received
transfusions in the previous 48 h in comparison to those
who had not received transfusions [5]. Del Vecchio et al.
described an association between the reduction of transfu-
sion rates and a lower incidence of bronchopulmonary
dysplasia, retinopathy of prematurity and necrotizing en-
terocolitis [32].
In the present study, premature newborns who re-
ceived RBC transfusions during hospital stay had a 3.8-
fold greater chance of developing enterocolitis and a
64 % greater chance of also having a diagnosis of grade
III to IV hemorrhage in comparison to those who did
not receive transfusions. However, it was not possible to
establish the temporal relationship between the transfu-
sions and these complications.
In a multicenter study involving tertiary neonatal care
units at university hospitals and a total of 1077 prema-
ture newborns (gestational age: 23.0 to 36.9 weeks; birth
weight: 400 to 1495 g), the relative risk of hospital death
was 49 % greater among those who received at least one
RBC transfusion in the first 28 days of life in comparison
to those who did not receive transfusions, after control-
ling for confounding factors. Moreover, the relative risk
of death after 28 days of life was 89 % greater among
newborns who received three or more RBC transfusions
during hospital stay in comparison to those who re-
ceived one or two transfusions [4]. While this associ-
ation was not investigated in the present study, it is a
cause of concern that half of the newborns analyzed re-
ceived at least one transfusion.
The use of an umbilical catheter was associated with a
greater frequency of RBC transfusions. This association
may have been due to the fact that umbilical catheters
are employed in premature infants with lower gesta-
tional ages and greater clinical severity. However, an um-
bilical catheter facilitates blood collection for laboratory
exams and can lead to greater blood loss, thereby in-
creasing the need for transfusions.
The use of supplementary oxygen at 28 days of life,
mechanical ventilation and vasoactive drugs were also
associated with the indication for transfusions possibly
due to the need for support to improve oxygenation
and/or tissue perfusion. In a study by Guillén et al. in-
volving 1018 neonatologists, the authors found that the
following variables had the greatest influence on the deci-
sion to submit very-low-birth-weight newborns to RBC
transfusions: the need for supplementary oxygen (44.7 % of
neonatologists), need for respiratory support (44.1 %), post-
natal age (36.5 %), number of reticulocytes (32.7 %) and
the use of inotropic drugs (30.9 %). These findings suggest
that the variables employed in the majority of guidelines
for the indication of transfusions are effectively used in
the clinical practice [28].
The variability in transfusion rates among the different
neonatal units studied may be explained by the clinical
diversity of the premature newborns cared at these ser-
vices. However, the differences among units persisted
even after adjusting for clinical variables considered risk
factors for blood transfusions. It is therefore possible
that several factors influenced the indication for transfu-
sions at these neonatal units, such as phlebotomy blood
loss, differences in the criteria employed for the indica-
tion of transfusions, the degree of compliance with exist-
ing protocols and other healthcare practices [33].
A reduction in phlebotomy blood loss is recognized as
the most effective measure for diminishing the need for
RBC transfusions. Madan et al. showed a 46 % reduction
in the number of transfusions in extremely-low-birth-
weight preterm infants using a bedside blood gas analyzer,
which reduced the volume of blood for laboratory exams
[34]. Mahieu et al. found a reduction in the percentage of
premature newborns that received transfusions after
adopting of a multi-parameter monitor for laboratory
analyses (50.0 % to 38.9 %, p < 0.05) and a 38 % reduction
in the number of transfusions per newborn (2.53 to 1.57;
p < 0.01) [35].
The adoption of restrictive guidelines for RBC transfu-
sions constitutes another measure for reducing the num-
ber transfusions. Venâncio et al. found that the use of
restrictive criteria led to a reduction of 16 mL/kg in the
volume of RBC transfused per newborn [36] and an 18 %
reduction in the number of transfusions [1]. These effects
are superior to those obtained with erythropoietin [2]. The
practice of delayed cord clamping or cord milking would
furher reduce the need for erythrocyte transfusions [37],
but this practice is not routinely stablished in most neo-
natal units [28], as well as in the Brazilian neonatal units.
The limitations of our study were its: cross sectional de-
sign, lack of data on phlebotomy blood loss and number
of transfusions per infant, and absence of data regarding
transfusion guideline adherence in each neonatal unit.
However the great number of neonates included and the
diversity of factors analyzed may have contributed to im-
prove the internal and external validity of this study.
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Conclusion
In conclusion, considerable variability was found among
the different neonatal units studied regarding the fre-
quency of RBC transfusions. Moreover, the influence of
the center regarding transfusion practices in very-low-
birth-weight newborns persisted even after controlling
for confounding factors. The demographic and clinical
characteristics of the patients, especially those related to
clinical severity and the need for invasive procedures,
were significantly associated with the indication for RBC
transfusions in very-low-birth-weight newborns.
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